Trial Profile
A retrospective study of dabrafenib in patients with metastatic melanoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Dec 2015
Price :
$35
*
At a glance
- Drugs Dabrafenib (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions
- 05 Dec 2015 New trial record